» Articles » PMID: 24997632

Co-occurrence of Autism and Asthma in a Nationally-representative Sample of Children in the United States

Overview
Publisher Springer
Date 2014 Jul 7
PMID 24997632
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Few large epidemiological studies have examined the co-occurrence of autism and asthma. We performed a cross-sectional study to examine this association using the 2007 National Survey of Children's Health dataset (n = 77,951). We controlled for confounders and tested for autism-secondhand smoke interaction. Prevalence of asthma and autism were 14.5 % (n = 11,335) and 1.81 % (n = 1,412) respectively. Unadjusted odds ratio (OR) for asthma among autistic children was 1.35 (95 % CI 1.18-1.55). Adjusting for covariates (age, gender, body mass index, race, brain injury, secondhand smoke and socio-economic status) attenuated the OR to 1.19 (95 % CI 1.03-1.36). Autism-secondhand smoke interaction was insignificant (p = 0.38). Asthma is approximately 35 % more common in autistic children; screening may be an efficient approach to reduce risk of morbidity due to asthma.

Citing Articles

The relationship between allergic diseases and neurodevelopmental disorders in children enrolled in primary healthcare.

Guclu Y, Erkoyun E, Celik S, Can D Pak J Med Sci. 2025; 41(2):404-408.

PMID: 39926657 PMC: 11803789. DOI: 10.12669/pjms.41.2.10691.


De novo network analysis reveals autism causal genes and developmental links to co-occurring traits.

Miller C, Golovina E, Wicker J, Jacobsen J, OSullivan J Life Sci Alliance. 2023; 6(10).

PMID: 37553252 PMC: 10410065. DOI: 10.26508/lsa.202302142.


Patients with autism in the emergency department: cause of admissions and challenges.

Bilginer C, Yildirim S, Torenek R, Ozkaya A Int J Dev Disabil. 2023; 69(5):710-716.

PMID: 37547546 PMC: 10402859. DOI: 10.1080/20473869.2021.2009996.


Geographic Variation in Preventable Hospitalizations among US Children with Autism.

Zhang W, Johnson K Children (Basel). 2023; 10(7).

PMID: 37508725 PMC: 10378360. DOI: 10.3390/children10071228.


Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials.

Arteaga-Henriquez G, Gisbert L, Ramos-Quiroga J CNS Drugs. 2023; 37(3):215-229.

PMID: 36913130 PMC: 10024667. DOI: 10.1007/s40263-023-00993-x.


References
1.
Moorman J, Anne Rudd R, Johnson C, King M, Minor P, Bailey C . National surveillance for asthma--United States, 1980-2004. MMWR Surveill Summ. 2007; 56(8):1-54. View

2.
Croen L, Grether J, Selvin S . Descriptive epidemiology of autism in a California population: who is at risk?. J Autism Dev Disord. 2002; 32(3):217-24. DOI: 10.1023/a:1015405914950. View

3.
Jyonouchi H, Geng L, Cushing-Ruby A, Quraishi H . Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation. 2008; 5:52. PMC: 2625336. DOI: 10.1186/1742-2094-5-52. View

4.
Croen L, Grether J, Yoshida C, Odouli R, Van de Water J . Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med. 2005; 159(2):151-7. DOI: 10.1001/archpedi.159.2.151. View

5.
Ghio A . Mechanism of asthmatic exacerbation by ambient air pollution particles. Expert Rev Respir Med. 2010; 2(1):109-18. DOI: 10.1586/17476348.2.1.109. View